Most human killer cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) cells and recognize HLA class I molecules as ligands. KIR3DL3 is a conserved but polymorphic inhibitory KIR recognizing a B7 family ligand, HHLA2, and is implicated for immune checkpoint targeting. The expression profile and biological function of KIR3DL3 have been somewhat elusive, so we searched extensively for KIR3DL3 transcripts, revealing highly enriched expression in γδ and CD8 + T cells rather than NK cells. These KIR3DL3-expressing cells are rare in the blood and thymus but more common in the lungs and digestive tract. High-resolution flow cytometry and single-cell transcriptomics showed that peripheral blood KIR3DL3 + T cells have an activated transitional memory phenotype and are hypofunctional. The T cell receptor (TCR) usage is biased toward genes from early rearranged TCR-α variable segments or Vδ1 chains. In addition, we show that TCR-mediated stimulation can be inhibited through KIR3DL3 ligation. Whereas we detected no impact of KIR3DL3 polymorphism on ligand binding, variants in the proximal promoter and at residue 86 can reduce expression. Together, we demonstrate that KIR3DL3 is up-regulated alongside unconventional T cell stimulation and that individuals may vary in their ability to express KIR3DL3. These results have implications for the personalized targeting of KIR3DL3/HHLA2 checkpoint inhibition.
Terpenoids are the largest and most diverse family of natural products. Volatile terpenes from Cannabis sativa are crucial in flavours, fragrances, and pharmaceuticals due to their unique odours and biological activities, including antimalarial, antibacterial, and insecticidal properties. Their synthesis is catalysed by terpene synthase (TPS) enzymes, which perform cyclisation and rearrangement reactions of over 55,000 distinct terpene compounds. However, low catalytic efficiency of C. sativa TPSs limits their use in large-scale commercial production. The complex biochemistry of these reactions is not well understood due to limited enzyme structure information. To address this, we have developed an integrated platform for the systematic expression, purification, enzymatic characterisation, and crystallisation of TPS enzymes from C. sativa. This workflow combines kinetic, thermostability, and structural analyses with a data-mining-informed crystallisation screen that enabled the production of diffraction-quality crystals. As a demonstration of the platform’s utility, ten C. sativa TPS enzymes were functionally characterised, revealing turnover rates (kcat) ranging from 0.0011 to 0.0204 s−1 and diverse substrate specificities, with each enzyme producing a distinct product profile, highlighting the need for systematic characterisation of C. sativa terpene biosynthesis. Our findings provide a framework for the structural and functional study of C. sativa TPSs. The developed platform sets the stage for future metabolic engineering aimed at optimising terpene production for pharmaceutical, pest management, and synthetic biology applications.
1 July 2025 in Biochemical and Biophysical Research Communications
Terpenes are the largest and most diverse class of natural products, essential for plant defence, ecological interactions, and environmental adaptation. Cannabis sativa is noted for its rich terpene profile, influencing aroma, flavour, and pharmacological properties. Limonene, a significant monoterpene, is commercially important in the fragrance and flavouring industries, making it a target for metabolic engineering. Terpene biosynthesis involves terpene synthase enzymes that convert isoprenoid diphosphates into diverse terpene scaffolds. Despite advances in terpene biochemistry, C. sativa TPSs lack structural characterisation. This study presents the first crystal structure of (-)-limonene synthase from C. sativa, offering insights into monoterpene biosynthesis. Solved at 3.2 Å resolution, the structure shows an "open" conformation with a solvent-accessible active site and disordered loops near the catalytic pocket, indicating a pre-catalytic state that aids substrate access. Biochemical characterisation confirmed limonene synthase as a highly specific monoterpene synthase, predominantly producing (-)-limonene from geranyl diphosphate with minor amounts of eight other monoterpenes. Kinetic analysis provided a Km of 7.809 ± 0.678 μM and a kcat of 0.0204 s-1, indicating moderate catalytic efficiency compared to other plant monoterpene synthases. These findings improve understanding of TPS function and set the stage for enzyme engineering to optimise terpene biosynthesis for industrial and biotechnological applications.
Cannabis sativa is a high-value plant renowned for its diverse chemical composition and abundant terpene content, contributing to its unique aroma, flavour, and therapeutic effects. Terpenes significantly influence consumer preference for C. sativa products, driving scientific interest in optimising terpene expression profiles and shaping the selective breeding of terpene profiles in C. sativa cultivars. In particular, the monoterpene, terpinolene, is influential in defining the sensory and therapeutic qualities of many C. sativa strains due to its woody, citrus-like aroma. Here we report the 2.5 Å resolution crystal structure of terpinolene synthase (CsTOS) from C. sativa in its apo form. The structure exhibits the class I monoterpene synthase fold with an open active site conformation. Using site-directed mutagenesis, we identified H618 as a key residues in determining product specificity. Substituting H618 with charged residues resulted in the preferential formation of limonene over terpinolene, highlighting its critical role in stabilising the substrate intermediate. Additionally, novel mutations uncovered an extended epistatic network of residues within 5 Å of the active site, spanning the α-helical bundle of the terpene synthase fold. These interactions contribute to monoterpene formation by modulating substrate positioning and catalytic activity. These insights advance our understanding of monoterpene biosynthesis and enable the targeted engineering of terpene synthases for customised terpene production, offering significant potential for the C. sativa industry.
1 July 2026 in Biochemical and Biophysical Research Communications